Article info

Download PDFPDF
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer
  1. Correspondence to Dr François Ghiringhelli, Georges-Francois Leclerc Cancer Centre, INSERM Avenir 866, 1 rue du Professeur Marion, Dijon 21000, France; fghiringhelli{at}dijon.fnclcc.fr
View Full Text

Citation

Guiu B, Petit JM, Bonnetain F, et al
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer

Publication history

  • Revised September 2, 2009
  • Accepted September 16, 2009
  • First published October 15, 2009.
Online issue publication 
March 05, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.